Want to see JP:6407 full AI Analyst Report?
Top Page
CKD Corporation
(6407)
Select Model
Select Model
Rating:72Outperform
Price Target:
¥7,459.00
▲(34.64% Upside)
Action:Reiterated
Date:06/19/26
The score is supported primarily by solid financial quality (strong profitability and conservative leverage) and strong technical momentum with the stock well above key moving averages. This is meaningfully offset by valuation risk, as the high P/E and modest yield suggest expectations are already elevated.
Positive Factors
Conservative Balance Sheet
Debt-to-equity near 0.16–0.29 (≈0.23 in 2026) provides durable financial flexibility. A conservatively levered balance sheet supports capital spending, cyclical downturn absorption and access to funding for strategic initiatives without immediate solvency pressure.
Negative Factors
Cash-Flow Volatility
Intermittent negative FCF in 2023–2024 and a large 2024 outflow indicate inconsistent cash conversion. This volatility raises execution risk on funding capex and working capital, could force short-term financing or delay strategic projects if adverse trends reappear.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Debt-to-equity near 0.16–0.29 (≈0.23 in 2026) provides durable financial flexibility. A conservatively levered balance sheet supports capital spending, cyclical downturn absorption and access to funding for strategic initiatives without immediate solvency pressure.
Read all positive factors
CKD Corporation (6407) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥484.51B
Dividend Yield2.5%
Average Volume (3M)472.93K
Price to Earnings (P/E)35.6
Beta (1Y)1.76
Revenue Growth1.45%
EPS Growth0.37%
CountryJP
Employees4,645
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)203.22
Shares Outstanding68,279,450
10 Day Avg. Volume518,100
30 Day Avg. Volume472,929
Financial Highlights & Ratios
PEG Ratio57.49
Price to Book (P/B)1.86
Price to Sales (P/S)1.81
P/FCF Ratio23.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥7,910.00Price Target Upside42.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)282.27
Revenue Forecast (FY)¥186.59B
CKD Corporation Business Overview & Revenue Model
Company Description
CKD Corporation is a global provider engaged in the design, manufacturing, sale, and export of industrial automation equipment and various components. The company operates through its Automatic Machinery and Component Products segments. Its extens...
How the Company Makes Money
CKD makes money primarily by manufacturing and selling industrial automation products and related systems to equipment makers and end-user manufacturers. Its core revenue streams typically include: (1) Pneumatic equipment sales—standard and custom...
CKD Corporation Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
84
Very Positive
Cash Flow
61
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 157.89B | 155.63B | 134.43B | 159.46B | 142.20B |
| Gross Profit | 45.74B | 44.16B | 37.04B | 45.48B | 40.09B |
| EBITDA | 28.01B | 26.73B | 20.30B | 28.37B | 24.09B |
| Net Income | 13.58B | 13.52B | 8.34B | 14.79B | 12.57B |
Balance Sheet | |||||
| Total Assets | 226.72B | 210.87B | 208.28B | 185.63B | 172.51B |
| Cash, Cash Equivalents and Short-Term Investments | 42.84B | 35.33B | 28.30B | 28.57B | 34.53B |
| Total Debt | 34.60B | 35.80B | 37.53B | 18.63B | 17.89B |
| Total Liabilities | 73.18B | 74.34B | 79.18B | 65.89B | 62.94B |
| Stockholders Equity | 153.54B | 136.52B | 129.10B | 119.73B | 109.57B |
Cash Flow | |||||
| Free Cash Flow | 12.23B | 13.47B | -12.26B | -7.00M | 4.47B |
| Operating Cash Flow | 14.83B | 19.17B | 7.60B | 11.05B | 12.35B |
| Investing Cash Flow | -1.19B | -6.06B | -20.23B | -12.79B | -8.54B |
| Financing Cash Flow | -7.06B | -6.18B | 13.05B | -5.74B | -6.26B |
CKD Corporation Technical Analysis
Positive
5540.00
Price Trends
6851.40
Positive
5936.59
Positive
4552.94
Positive
Market Momentum
86.72
Positive
51.65
Neutral
23.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6407, the sentiment is Positive. The current price of 5540 is below the 20-day moving average (MA) of 7463.50, below the 50-day MA of 6851.40, and above the 200-day MA of 4552.94, indicating a neutral trend. The MACD of 86.72 indicates Positive momentum. The RSI at 51.65 is Neutral, neither overbought nor oversold. The STOCH value of 23.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6407.
CKD Corporation Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥70.04B | 12.94 | ― | 3.95% | 2.75% | 25.74% | |
74 Outperform | ¥634.93B | 40.15 | 5.25% | 2.13% | -7.11% | 68.57% | |
72 Outperform | ¥484.51B | 35.58 | ― | 2.50% | 1.45% | 0.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥758.55B | 463.80 | 5.94% | 0.56% | 7.03% | -53.53% | |
56 Neutral | ¥861.22B | 60.45 | 1.88% | 6.16% | 1.98% | -48.28% | |
54 Neutral | ¥350.57B | 26.37 | ― | 1.65% | 5.02% | 19.84% |
* Industrials Sector Average
JP:6407
CKD Corporation
7,230.00
4,683.82
183.95%
JP:6324
Harmonic Drive Systems
7,880.00
5,333.80
209.48%
JP:6268
Nabtesco
5,428.00
2,817.68
107.94%
JP:6481
THK Co
7,688.00
3,994.63
108.16%
JP:6381
ANEST IWATA Corp.
1,760.00
380.34
27.57%
JP:6622
Daihen Corporation
15,590.00
9,067.25
139.01%
CKD Corporation Corporate Events
CKD Corporation Reveals JPY 178 Million Embezzlement at Subsidiary, Tightens Controls
Jul 9, 2026
CKD Corporation disclosed that a former accounting staff member at consolidated subsidiary CKD GLOBAL SERVICE CORP. was arrested on suspicion of embezzling company funds by repeatedly transferring money from corporate accounts to a personal accoun...
CKD Corporation Grants Restricted Treasury Stock to Align Directors With Long-Term Growth
Jun 26, 2026
CKD Corporation has approved the disposal of 5,088 shares of its treasury stock as restricted stock compensation for three internal directors, with a total value of approximately 39.9 million yen. The shares will be granted at 7,840 yen per share,...
CKD Overhauls Board Structure Ahead of Governance Transition
May 15, 2026
CKD Corporation has approved a slate of board candidates and executive officer changes as it prepares to transition to a Company with an Audit and Supervisory Committee structure, effective June 26, 2026. The proposal includes maintaining Presiden...
CKD Revamps Governance Structure With Shift to Audit and Supervisory Committee
May 15, 2026
CKD Corporation plans to change its governance structure by transitioning from a company with an Audit Supervisory Board to a company with an Audit and Supervisory Committee, subject to shareholder approval at its June 2026 annual meeting. The mo...
CKD Corporation Raises Year-End Dividend, Lifts Full-Year Payout to ¥81
May 15, 2026
CKD Corporation’s board has approved a year-end dividend of ¥49 per share for the fiscal year ended March 31, 2026, up from the prior forecast of ¥35 and higher than the previous year’s ¥42. The payout, sourced from reta...
CKD Corporation Posts Steady FY2026 Results and Lifts Dividend Outlook
May 15, 2026
CKD Corporation reported a modest increase in consolidated net sales to ¥157.9 billion for the year ended March 31, 2026, with operating profit up 3.3% and profit attributable to owners of parent edging 0.4% higher, while maintaining double-d...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.